These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Neurologic indications for bromocriptine (in addition to Parkinson's disease)]. Destee A LARC Med; 1984 Feb; 4(2):107-11. PubMed ID: 6232436 [No Abstract] [Full Text] [Related]
4. [Cholinergizing treatment in hyperkinesis]. Domzał T Neurol Neurochir Pol; 1978; 12(3):257-61. PubMed ID: 150548 [TBL] [Abstract][Full Text] [Related]
5. Lithium therapy in Huntington's chorea and tardive dyskinesia. Dalén P Lancet; 1973 Jan; 1(7794):107-8. PubMed ID: 4118636 [No Abstract] [Full Text] [Related]
6. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias. Jankovic J; Orman J Neurology; 1988 Mar; 38(3):391-4. PubMed ID: 3279337 [TBL] [Abstract][Full Text] [Related]
7. [Therapeutical approach to involuntary movements (author's transl)]. Allain H; Sabouraud O Sem Hop; 1979 Feb 8-15; 55(5-6):262-4. PubMed ID: 219537 [TBL] [Abstract][Full Text] [Related]
8. Tetrabenazine in the treatment of hyperkinetic movement disorders. Kenney C; Jankovic J Expert Rev Neurother; 2006 Jan; 6(1):7-17. PubMed ID: 16466307 [TBL] [Abstract][Full Text] [Related]
9. Lithium carbonate in the treatment of movement disorders. A critical review. Yassa R; Ananth J Int Pharmacopsychiatry; 1980; 15(5):301-8. PubMed ID: 6114936 [TBL] [Abstract][Full Text] [Related]
16. Clozapine therapy for Parkinson's disease and other movement disorders. Pfeiffer C; Wagner ML Am J Hosp Pharm; 1994 Dec; 51(24):3047-53. PubMed ID: 7856623 [TBL] [Abstract][Full Text] [Related]
17. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. Chen JJ; Ondo WG; Dashtipour K; Swope DM Clin Ther; 2012 Jul; 34(7):1487-504. PubMed ID: 22749259 [TBL] [Abstract][Full Text] [Related]
18. Deanol in the management of involuntary movement disorders: a review. Casey DE Dis Nerv Syst; 1977 Dec; 38(12 Pt 2):7-15. PubMed ID: 145359 [No Abstract] [Full Text] [Related]
19. The effect of lithium on the "on-off" phenomenon in parkinsonism. Coffey CE; Ross DR; Ferren EL; Bragdon AC; Hurwitz BJ; Olanow CW Adv Neurol; 1983; 37():61-73. PubMed ID: 6858779 [No Abstract] [Full Text] [Related]
20. The trial use of clozapine for abnormal involuntary movement disorders. Caine ED; Polinsky RJ; Kartzinel R; Ebert MH Am J Psychiatry; 1979 Mar; 136(3):317-20. PubMed ID: 154301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]